TBT
VC Fund
Seoul, South Korea
TBT is an Adventure Capital.We are more than your average VC investor; we are always up for an adventure. Investment means more than just transfer of capital for us. We want to be a discussion partner that discovers possibilities beyond risk and aligns growth with progress. We want to share decades of industry knowledge and experience in internetand mobile services to build services and products that can make the world a better place.
- Total investments:
- 56
- Last investment:
- Lead investor:
- 27%
Last updated:
For AI agents: llms.txt
Industries TBT invests in
Stages TBT invests in
Countries TBT invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $743k–$5.1M
- Series A
- $678k–$18M
- Series B
- $3M–$16M
Investment Focus
Industry
- Software 8 (14%)
- Information Technology 7 (13%)
- Health Care 6 (11%)
- Artificial Intelligence 6 (11%)
- Beauty 5 (9%)
Stage
- Series A 17 (30%)
- Seed 14 (25%)
- Series B 10 (18%)
- Series C 4 (7%)
- Venture - Series Unknown 2 (4%)
Country
- South Korea 35 (63%)
- United States 2 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jin Park
Investment Manager
|
Investment Manager | Total investments: 0 | Find email | |
Dongoh Kim
Corporate Lawyer
|
Corporate Lawyer | Total investments: 2 | Find email | |
|
Lee Chung-wook
Team leader
|
Team leader | Total investments: 4 | Find email | |
|
Ram Lee
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 12 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Medistream operates an integrated platform for oriental medicine. | $19M / Series C / Dec 24, 2025 | ||
| JNPMEDI is a Clinical Trial Platforms company that offers services as a Clinical Research Organization (CRO), investment assistance, and licensing consulting. It also delivers clinical data management and operational services that adhere to international standards via its proprietary platform. The organization provides capabilities for clinicaldata management, operations, clinical trials, and quality control, all grounded in international standards through its unique platform. | Series B / Aug 13, 2025 | ||
| Two Slash For is a beauty brand. | Seed / Jul 29, 2024 | ||
| Medistream operates an integrated platform for oriental medicine. | $17.1M / Series C / Apr 02, 2024 | ||
| Two Slash For is a beauty brand. | Seed / Feb 23, 2023 | ||
| Medistream operates an integrated platform for oriental medicine. | $8.1M / Series B / Jan 16, 2023 | ||
| FREECO is a content provider for businesses. Consultation, sales, and software development and supply Cosmetics wholesale and retail business Marketing consulting and advertising business. | $1.9M / Series A / Jan 11, 2023 | ||
| SuperBin is a company that uses AI to create a culture where our society can share and practice the value of circulating resources. | $12.5M / Series B / Oct 14, 2022 | ||
| Sentbe is creating finance without borders. As a fintech money transfer service, Sentbe provides an easier, faster, and more convenient way to transfer money abroad. | $10.8M / Series C / Sep 13, 2022 | ||
| Atlas Labs develops and delivers language-based AI solutions. | $6.5M / Series A / Sep 07, 2022 | ||
| See all 56 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does TBT invest in?
TBT invests primarily in Software, Information Technology and Health Care startups, most often at Series A and Seed stage. Most of the 56 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is TBT's check size?
TBT typically joins rounds of $743k–$5.1M at Seed, $678k–$18M at Series A and $3M–$16M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds TBT participates in.
How do I contact TBT?
Public channels for TBT include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at TBT?
The team at TBT includes Jin Park (Investment Manager), Dongoh Kim (Corporate Lawyer) and Lee Chung-wook (Team leader). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
